Skip Navigation

February 15, 2008

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

NIAID AIDS Vaccine Research Subcommittee
Meeting Postponed

The AIDS Vaccine Research Subcommittee (AVRS), a component of the National Institute of Allergy and Infectious Diseases (NIAID) AIDS Research Advisory Committee, will not meet as scheduled on March 3, 2008, in Bethesda, Md. Instead, the subcommittee meeting has been postponed until after NIAID holds a scientific summit on March 25 to gather input on the scope and balance of its HIV vaccine research activities. Information regarding the summit, which will be webcast, will be posted to the NIAID Web site in coming weeks.

Postponing the AVRS meeting will enable the subcommittee members to incorporate the perspectives voiced at the summit with other data in their further consideration of the proposed large-scale, international HIV vaccine study known as PAVE 100. The additional time also will enable the PAVE 100 protocol team to more fully evaluate data from the STEP study, including new data presented on February 5 at the Conference on Retroviruses and Opportunistic Infections in Boston.

The AVRS meeting will be rescheduled for this spring, and details about the meeting will be published in the Federal Register.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit

NIH...Turning Discovery Into Health ®

back to top

Last Updated February 15, 2008